A feel good story - nothing more.
......
Wilson Asset Management chief investment officer Chris Stott
Two stocks, Slater & Gordon and Sirtex Medical, would be worthwhile additions. A market-leading law firm in Australia and Britain, Slater & Gordon has a strong management team, strong growth prospects over the longer term and it offers both capital and income growth to investors over time.
Sirtex makes and distributes liver cancer treatments primarily with its SIR-Spheres microspheres technology. Liver cancer is the fifth-most common cancer worldwide.
In the coming years, the company will receive results which could potentially widen the use of this technology and open up larger parts of the market.
......
Add to My Watchlist
What is My Watchlist?